Selected research
Market Analysis & Forecast
Global Laboratory Pathology Service Market Analysis and Forecast 2026-2032
Market perspective
The global Laboratory Pathology Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Laboratory Pathology Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Laboratory Pathology Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Laboratory Pathology Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Laboratory Pathology Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Laboratory Pathology Service include Acupath Laboratories, Annapath Pathology Services, CellNetix Pathology & Laboratories, Charles River Laboratories, Coronis Health, Innovative Pathology Services, LMC Pathology Services, Pathology Laboratories and Pathology Laboratory Associates, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Laboratory Pathology Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Laboratory Pathology Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Laboratory Pathology Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Laboratory Pathology Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Laboratory Pathology Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Laboratory Pathology Service revenue, projected growth trends, production technology, application and end-user industry.
Laboratory Pathology Service Segment by Company
Acupath Laboratories
Annapath Pathology Services
CellNetix Pathology & Laboratories
Charles River Laboratories
Coronis Health
Innovative Pathology Services
LMC Pathology Services
Pathology Laboratories
Pathology Laboratory Associates
QDx Pathology
Sonic Healthcare USA
StrataDx
Laboratory Pathology Service Segment by Type
Clinical Immunology
Clinical Microbiology
Clinical Molecular Biology
Others
Laboratory Pathology Service Segment by Application
Disease Diagnosis
Therapeutic Effect Evaluation
Disease Prevention and Screening
Clinical Research and Teaching
Others
Laboratory Pathology Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory Pathology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Laboratory Pathology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory Pathology Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Laboratory Pathology Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Laboratory Pathology Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Laboratory Pathology Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Clinical Immunology
- Clinical Microbiology
- Clinical Molecular Biology
- Others
Applications
- Disease Diagnosis
- Therapeutic Effect Evaluation
- Disease Prevention and Screening
- Clinical Research and Teaching
- Others
Companies covered
- Acupath Laboratories
- Annapath Pathology Services
- CellNetix Pathology & Laboratories
- Charles River Laboratories
- Coronis Health
- Innovative Pathology Services
- LMC Pathology Services
- Pathology Laboratories
- Pathology Laboratory Associates
- QDx Pathology
- Sonic Healthcare USA
- StrataDx
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Laboratory Pathology Service Market by Type
- 1.2.1 Global Laboratory Pathology Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Clinical Immunology
- 1.2.3 Clinical Microbiology
- 1.2.4 Clinical Molecular Biology
- 1.2.5 Others
- 1.3 Laboratory Pathology Service Market by Application
- 1.3.1 Global Laboratory Pathology Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Disease Diagnosis
- 1.3.3 Therapeutic Effect Evaluation
- 1.3.4 Disease Prevention and Screening
- 1.3.5 Clinical Research and Teaching
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Laboratory Pathology Service Market Dynamics
- 2.1 Laboratory Pathology Service Industry Trends
- 2.2 Laboratory Pathology Service Industry Drivers
- 2.3 Laboratory Pathology Service Industry Opportunities and Challenges
- 2.4 Laboratory Pathology Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Laboratory Pathology Service Market Perspective (2021-2032)
- 3.2 Global Laboratory Pathology Service Growth Trends by Region
- 3.2.1 Global Laboratory Pathology Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Laboratory Pathology Service Market Size by Region (2021-2026)
- 3.2.3 Global Laboratory Pathology Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Laboratory Pathology Service Revenue by Players
- 4.1.1 Global Laboratory Pathology Service Revenue by Players (2021-2026)
- 4.1.2 Global Laboratory Pathology Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Laboratory Pathology Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Laboratory Pathology Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Laboratory Pathology Service Key Players Headquarters & Area Served
- 4.4 Global Laboratory Pathology Service Players, Product Type & Application
- 4.5 Global Laboratory Pathology Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Laboratory Pathology Service Market CR5 and HHI
- 4.6.3 2025 Laboratory Pathology Service Tier 1, Tier 2, and Tier 3
5 Laboratory Pathology Service Market Size by Type
- 5.1 Global Laboratory Pathology Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Laboratory Pathology Service Revenue by Type (2021-2032)
- 5.3 Global Laboratory Pathology Service Revenue Market Share by Type (2021-2032)
6 Laboratory Pathology Service Market Size by Application
- 6.1 Global Laboratory Pathology Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Laboratory Pathology Service Revenue by Application (2021-2032)
- 6.3 Global Laboratory Pathology Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Acupath Laboratories
- 7.1.1 Acupath Laboratories Company Information
- 7.1.2 Acupath Laboratories Business Overview
- 7.1.3 Acupath Laboratories Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Acupath Laboratories Laboratory Pathology Service Product Portfolio
- 7.1.5 Acupath Laboratories Recent Developments
- 7.2 Annapath Pathology Services
- 7.2.1 Annapath Pathology Services Company Information
- 7.2.2 Annapath Pathology Services Business Overview
- 7.2.3 Annapath Pathology Services Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Annapath Pathology Services Laboratory Pathology Service Product Portfolio
- 7.2.5 Annapath Pathology Services Recent Developments
- 7.3 CellNetix Pathology & Laboratories
- 7.3.1 CellNetix Pathology & Laboratories Company Information
- 7.3.2 CellNetix Pathology & Laboratories Business Overview
- 7.3.3 CellNetix Pathology & Laboratories Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.3.4 CellNetix Pathology & Laboratories Laboratory Pathology Service Product Portfolio
- 7.3.5 CellNetix Pathology & Laboratories Recent Developments
- 7.4 Charles River Laboratories
- 7.4.1 Charles River Laboratories Company Information
- 7.4.2 Charles River Laboratories Business Overview
- 7.4.3 Charles River Laboratories Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Charles River Laboratories Laboratory Pathology Service Product Portfolio
- 7.4.5 Charles River Laboratories Recent Developments
- 7.5 Coronis Health
- 7.5.1 Coronis Health Company Information
- 7.5.2 Coronis Health Business Overview
- 7.5.3 Coronis Health Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Coronis Health Laboratory Pathology Service Product Portfolio
- 7.5.5 Coronis Health Recent Developments
- 7.6 Innovative Pathology Services
- 7.6.1 Innovative Pathology Services Company Information
- 7.6.2 Innovative Pathology Services Business Overview
- 7.6.3 Innovative Pathology Services Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Innovative Pathology Services Laboratory Pathology Service Product Portfolio
- 7.6.5 Innovative Pathology Services Recent Developments
- 7.7 LMC Pathology Services
- 7.7.1 LMC Pathology Services Company Information
- 7.7.2 LMC Pathology Services Business Overview
- 7.7.3 LMC Pathology Services Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.7.4 LMC Pathology Services Laboratory Pathology Service Product Portfolio
- 7.7.5 LMC Pathology Services Recent Developments
- 7.8 Pathology Laboratories
- 7.8.1 Pathology Laboratories Company Information
- 7.8.2 Pathology Laboratories Business Overview
- 7.8.3 Pathology Laboratories Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Pathology Laboratories Laboratory Pathology Service Product Portfolio
- 7.8.5 Pathology Laboratories Recent Developments
- 7.9 Pathology Laboratory Associates
- 7.9.1 Pathology Laboratory Associates Company Information
- 7.9.2 Pathology Laboratory Associates Business Overview
- 7.9.3 Pathology Laboratory Associates Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Pathology Laboratory Associates Laboratory Pathology Service Product Portfolio
- 7.9.5 Pathology Laboratory Associates Recent Developments
- 7.10 QDx Pathology
- 7.10.1 QDx Pathology Company Information
- 7.10.2 QDx Pathology Business Overview
- 7.10.3 QDx Pathology Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.10.4 QDx Pathology Laboratory Pathology Service Product Portfolio
- 7.10.5 QDx Pathology Recent Developments
- 7.11 Sonic Healthcare USA
- 7.11.1 Sonic Healthcare USA Company Information
- 7.11.2 Sonic Healthcare USA Business Overview
- 7.11.3 Sonic Healthcare USA Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Sonic Healthcare USA Laboratory Pathology Service Product Portfolio
- 7.11.5 Sonic Healthcare USA Recent Developments
- 7.12 StrataDx
- 7.12.1 StrataDx Company Information
- 7.12.2 StrataDx Business Overview
- 7.12.3 StrataDx Laboratory Pathology Service Revenue and Gross Margin (2021-2026)
- 7.12.4 StrataDx Laboratory Pathology Service Product Portfolio
- 7.12.5 StrataDx Recent Developments
8 North America
- 8.1 North America Laboratory Pathology Service Revenue (2021-2032)
- 8.2 North America Laboratory Pathology Service Revenue by Type (2021-2032)
- 8.2.1 North America Laboratory Pathology Service Revenue by Type (2021-2026)
- 8.2.2 North America Laboratory Pathology Service Revenue by Type (2027-2032)
- 8.3 North America Laboratory Pathology Service Revenue Share by Type (2021-2032)
- 8.4 North America Laboratory Pathology Service Revenue by Application (2021-2032)
- 8.4.1 North America Laboratory Pathology Service Revenue by Application (2021-2026)
- 8.4.2 North America Laboratory Pathology Service Revenue by Application (2027-2032)
- 8.5 North America Laboratory Pathology Service Revenue Share by Application (2021-2032)
- 8.6 North America Laboratory Pathology Service Revenue by Country
- 8.6.1 North America Laboratory Pathology Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Laboratory Pathology Service Revenue by Country (2021-2026)
- 8.6.3 North America Laboratory Pathology Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Laboratory Pathology Service Revenue (2021-2032)
- 9.2 Europe Laboratory Pathology Service Revenue by Type (2021-2032)
- 9.2.1 Europe Laboratory Pathology Service Revenue by Type (2021-2026)
- 9.2.2 Europe Laboratory Pathology Service Revenue by Type (2027-2032)
- 9.3 Europe Laboratory Pathology Service Revenue Share by Type (2021-2032)
- 9.4 Europe Laboratory Pathology Service Revenue by Application (2021-2032)
- 9.4.1 Europe Laboratory Pathology Service Revenue by Application (2021-2026)
- 9.4.2 Europe Laboratory Pathology Service Revenue by Application (2027-2032)
- 9.5 Europe Laboratory Pathology Service Revenue Share by Application (2021-2032)
- 9.6 Europe Laboratory Pathology Service Revenue by Country
- 9.6.1 Europe Laboratory Pathology Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Laboratory Pathology Service Revenue by Country (2021-2026)
- 9.6.3 Europe Laboratory Pathology Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Laboratory Pathology Service Revenue (2021-2032)
- 10.2 China Laboratory Pathology Service Revenue by Type (2021-2032)
- 10.2.1 China Laboratory Pathology Service Revenue by Type (2021-2026)
- 10.2.2 China Laboratory Pathology Service Revenue by Type (2027-2032)
- 10.3 China Laboratory Pathology Service Revenue Share by Type (2021-2032)
- 10.4 China Laboratory Pathology Service Revenue by Application (2021-2032)
- 10.4.1 China Laboratory Pathology Service Revenue by Application (2021-2026)
- 10.4.2 China Laboratory Pathology Service Revenue by Application (2027-2032)
- 10.5 China Laboratory Pathology Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Laboratory Pathology Service Revenue (2021-2032)
- 11.2 Asia Laboratory Pathology Service Revenue by Type (2021-2032)
- 11.2.1 Asia Laboratory Pathology Service Revenue by Type (2021-2026)
- 11.2.2 Asia Laboratory Pathology Service Revenue by Type (2027-2032)
- 11.3 Asia Laboratory Pathology Service Revenue Share by Type (2021-2032)
- 11.4 Asia Laboratory Pathology Service Revenue by Application (2021-2032)
- 11.4.1 Asia Laboratory Pathology Service Revenue by Application (2021-2026)
- 11.4.2 Asia Laboratory Pathology Service Revenue by Application (2027-2032)
- 11.5 Asia Laboratory Pathology Service Revenue Share by Application (2021-2032)
- 11.6 Asia Laboratory Pathology Service Revenue by Country
- 11.6.1 Asia Laboratory Pathology Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Laboratory Pathology Service Revenue by Country (2021-2026)
- 11.6.3 Asia Laboratory Pathology Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Laboratory Pathology Service Revenue (2021-2032)
- 12.2 SAMEA Laboratory Pathology Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Laboratory Pathology Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Laboratory Pathology Service Revenue by Type (2027-2032)
- 12.3 SAMEA Laboratory Pathology Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Laboratory Pathology Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Laboratory Pathology Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Laboratory Pathology Service Revenue by Application (2027-2032)
- 12.5 SAMEA Laboratory Pathology Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Laboratory Pathology Service Revenue by Country
- 12.6.1 SAMEA Laboratory Pathology Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Laboratory Pathology Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Laboratory Pathology Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst